I just want to highlight this very important point because it is true, I looked it up. Also, thanks.
"Now here's something all of you should be aware of and likely are NOT, but I will educate you...only 5 in 5,000 New Patents for Drug development via filing an IND make it to the pre-clinical testing phase on human subjects. Then subsequently, of those 5, only 1 makes it past pre-clinical then onward to all phase completion preparing for treatment application which is the case with RGBP! FACT! If this was NOT the case they would NOT have been looked at twice by ANY BIG PHARMA!!!"